Autolus Therapeutics PLC Sponsored ADR (AUTL) vs SAB Biotherapeutics, Inc. (SABS)
- Autolus Therapeutics PLC Sponsored ADR AUTL 0.91 −7.14%
- SAB Biotherapeutics, Inc. SABS 2.81 −3.44%
Autolus Therapeutics PLC Sponsored ADR and SAB Biotherapeutics, Inc. are both Biotechnology companies. Autolus Therapeutics PLC Sponsored ADR and SAB Biotherapeutics, Inc. are of similar size ($262.2M and $260.9M). Autolus Therapeutics PLC Sponsored ADR grew revenue faster over the last twelve months: 168.8% against −56.7%. Autolus Therapeutics PLC Sponsored ADR has the higher net margin (−186.4% vs −1,450.3%) and the higher return on invested capital (0.00% vs −48.4%). Across the 17 metrics below, SAB Biotherapeutics, Inc. leads on 9 and Autolus Therapeutics PLC Sponsored ADR on 8.
Valuation
Profitability
| Metric | AUTL | SABS | Biotechnology median |
|---|---|---|---|
| Gross margin | 35.76% | 100.00% | 70.18% |
| Operating margin | (159.61%) | (1,647.03%) | 0.00% |
| Net margin | (186.37%) | (1,450.32%) | 0.00% |
| Free cash flow margin | (131.12%) | (1,344.29%) | 0.00% |
| Return on equity | (174.92%) | (47.62%) | (51.58%) |
| Return on assets | (43.23%) | (42.73%) | (45.91%) |
| Return on invested capital | 0.00% | (48.38%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack